Webinars & e-learning courses All webinars

LIVE-STREAM: EXCLUSIVE ONCOLOGY VETGRUPPEN CONFERENCE

LIVE-STREAM: EXCLUSIVE ONCOLOGY VETGRUPPEN CONFERENCE
LIVE-STREAM: EXCLUSIVE ONCOLOGY VETGRUPPEN CONFERENCE

Revolutionizing Veterinary Oncology – Innovations You Can Use Today! 

Join VetGruppen Germany for an exclusive, cutting-edge event where veterinary oncology meets real-world practice. Discover the latest breakthroughs in cancer detection, treatment, and patient care—designed to elevate your clinic’s oncology expertise.

Keynote Speaker: Dr. Sue Ettinger!

We’re thrilled to welcome the renowned Dr. Sue Ettinger, who will deliver two powerhouse sessions packed with cutting-edge oncology insights! 

  • “My Favorite Cancer Tools for Everyday Practice 2025: Bringing Innovation to Your Oncology Toolbox” 
  • “Beyond Prednisone: Rethinking Lymphoma Management in General Practice” Simultaneous translation available 

 

AGENDA SATURDAY, MARCH 22, 2025 

1:00 PM – 2:30 PM Keynote by Dr. Sue Ettinger: My Favorite Cancer Tools for Everyday Practice 2025: Bringing Innovation to Your Oncology Toolbox 

  • Innovative Cancer Detection & Diagnostics 
  • Breakthrough Treatments
  • Takeaway: Discover cutting-edge tools and strategies that bring oncology innovations into everyday veterinary practice! 

2:30 PM – 2:45 PM Q&A 

2:45 PM – 3:15 PM Break 

3:15 PM – 4:45 PM Keynote by Dr. Sue Ettinger: Beyond Prednisone: Rethinking Lymphoma Management in General Practice 

  • Beyond Prednisone: Smarter Treatment Strategies 
  • Latest Treatment Options 
  • When Chemotherapy Isn't an Option 
  • Takeaway: Stay ahead with cutting-edge insights to optimize canine lymphoma treatment in everyday veterinary care! 

4:45 PM – 5:15 PM Q&A 

 

ATF-Anerkennung gemäß §§ 10, 12 der ATF-Statuten: 4 Stunden

Recorded on March 21, 2025

Speaker:

IMG_7393.jpg

Sue Ettinger

DVM, DACVIM (Oncology)

Dr. Sue Ettinger, DVM, DACVIM (Oncology), is a board-certified veterinary oncologist, international speaker, author, and vlogger. She is one of approximately 450 board-certified specialists in medical oncology in North America and currently practices at Guardian Veterinary Specialists in Brewster, NY.

She earned her veterinary degree from Cornell University College of Veterinary Medicine and completed her medical oncology residency at the Animal Medical Center in NYC in 2003.

Dr. Sue is widely recognized for her contributions to veterinary medicine. She was voted 2019 WVC Small Animal Continuing Educator of the Year and has received awards for Exceptional Doctor Performance and Public Relations Achievement. She co-authored the best-selling Second Edition of The Dog Cancer Survival Guide and frequently contributes to major veterinary publications such as Today’s Veterinary Practice, Clinician’s Brief, and DVM360. She has also co-hosted The Pet Cancer Vet podcast and is a regular guest on veterinary media platforms.

As a dedicated advocate for cancer awareness and early detection, Dr. Sue developed the “See Something, Do Something, Why Wait? Aspirate.®” initiative, encouraging early diagnosis of skin and subcutaneous tumors in pets. Her approach focuses on compassionate cancer care, aiming to improve the quality of life for pets undergoing treatment.

A native of Long Island, NY, Dr. Sue has wanted to be a veterinarian since childhood. She now lives in Westchester, NY, with her two sons and two Labrador Retrievers, Matilda and Penelope.

Booking information

Duration: 2:57 h
Speaker: Sue Ettinger
from 1
219.60 US$
(inkl. tax)

You might also be interested in

tumor-grading-and-prognosis-in-veterinary-practice-1.jpeg
Sara Belluco
0:44 h

Tumor grading and prognosis in veterinary practice

Tumors are quite frequent in companion animals, with malignant forms representing 56% of all the tumors in dogs and 80% in cats. Predicting the survival time and treatment response for malignant tumors is necessary to evaluate the best care options for the animal. Histological tumor grading helps veterinarians to define the prognosis, but each tumor has its own grading system with different prognosis, in terms of survival rate, metastatic rate, recurrence incidence. It could be not so easy to get your bearings in the pathologic words of gradings. The goal of this seminar is to be able to correlate the validated prognosis to each tumor grading we will see. We will rapidly review what tumor grading is and how it is evaluated. Then we will spend some time to review some of the most important tumor gradings (mammary tumors, mast cell tumors, melanomas, soft tissue sarcomas) and the correlated and validated prognostic factors. At the end of the seminar you will be able to clearly understand your pathologist’s report based on the grading system, and to use it to give an appropriate prognosis to the owners.
veterinary-gb0489bee6_1920300x200.jpg
Penny Thomas
0:51 h

Supportive Care for Cancer Patients for Nurses

How to provide the best nursing care for patients with cancer 
canine-and-feline-lymphoma-diagnosis-and-treatment-1.jpeg
Peter Bennett
0:59 h

Canine and feline lymphoma - diagnosis and treatment

Canine and feline lymphoma is a relatively common disease but there are some areas where potential complications arise. This webinar will concentrate on the diagnostic tests that can be utilised for this disease and the common treatments, with an emphasis on how the diagnostic tests can influence the treatment and prognosis. In dogs, diagnosis is usually relatively straightforward, but it can be more of a challenge in cats due to the differences in clinical presentation. The standard initial treatment options are well described, but how they need to be modified dependent on concurrent illnesses, diagnostic test findings and owner constraints can be more complicated. My approach to these issues will be described including how they might impact the patient outcome, as well as alternatives. The monitoring of the patients and an overview of the management of complications of the disease and treatment is to be covered. The webinar will conclude with rescue options. Lymphoma can be a rewarding disease to treat, but can be very challenging at times.